Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study
Recruiting now · Not applicable
Conditions studied: Parkinson's Disease
In brief
This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.
Key facts
- Study ID
- NCT07380737
- Run by
- Tel-Aviv Sourasky Medical Center
- People needed
- 30
- Starts
- 2025-12-29
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-02-13
Who can join
Age: 40 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria);
- Hoehn \& Yahr stage II-III (ON-medication state);
- Able to walk independently for ≥5 minutes;
- Stable medication for ≥1 month;
- Currently enrolled in a rehab program at Ezra LeMarpe;
- Able to provide written informed consent;
You may not qualify if…
- Musculoskeletal, neurological, or visual/hearing impairments affecting gait;
- Cognitive impairments or severe behavioral symptoms;
- History of stroke, severe TBI, or brain tumor;
- Cardiovascular contraindications;
- Inability to use a smartphone;
- Participation in other concurrent intervention studies.
Where it is running
- Tel Aviv Sourasky Medical Center (Ichilov Hospital) — Tel Aviv, Israel (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.